Skip to main content
Fig. 6 | Clinical Epigenetics

Fig. 6

From: Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel

Fig. 6

Scatter plot of a RASSF1A promoter methylation levels between clinical stage I & II (n = 17) and III & IV (n = 85) LC patients. b GSTP1 promoter methylation levels between clinical stage I (n = 31), II (n = 55) and III & IV (n = 35) PCa patients. c (1) RARβ2 and (2) SEPT9 promoters’ methylation levels between clinical stage I & II (n = 39) and III & IV (n = 61) CRC patients. Mann-Whitney U Test for a and c and Mann-Whitney U test with Bonferroni’s correction for b, n.s. p < 0.05, *p < 0.05. Red horizontal lines represent median methylation

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us